Systemic lupus erythematosus, or SLE, is an autoimmune disease that can affect any part of the body, and about half the people with it develop lupus nephritis. In a Cochrane Review that was updated in December 2012, Lorna Henderson from the University of Sydney at Westmead in Australia and colleagues, brought together the studies that have tested a range of treatments.